{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:30:16Z","timestamp":1794267016564,"version":"4.9.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Leading talents entrepreneurship of Guangzhou Municipal Government","award":["LCY201306"],"award-info":[{"award-number":["LCY201306"]}]},{"name":"Leading talents entrepreneurship of Guangzhou Municipal Government","award":["2009ZX09301-015"],"award-info":[{"award-number":["2009ZX09301-015"]}]},{"name":"Leading talent project in science and technology of Guangzhou Development"},{"name":"South China Comprehensive Platform for New Medicine R&D"},{"name":"DELI Biological Industry Co., Ltd"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijpharm.2016.09.036","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T19:47:12Z","timestamp":1473709632000},"page":"347-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Comparison in toxicity and solubilizing capacity of hydroxypropyl-\u03b2-cyclodextrin with different degree of substitution"],"prefix":"10.1016","volume":"513","author":[{"given":"Pengyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanna","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suizhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.09.036_bib0005","first-page":"285","article-title":"Toxicological evaluation of hydroethanolic extract of Helicteres sacarolha A. St.- Hil. et al","volume":"157","author":"Balogun","year":"2014","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaccutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jps.2600840220","article-title":"Safety of parenteral hydroxypropyl beta-cyclodextrin","volume":"84","author":"Carpenter","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0020","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nrd1576","article-title":"Cyclodextrin-based pharmaceutics: past, present and future","volume":"3","author":"Davis","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jpba.2011.02.022","article-title":"Solubilization of ibuprofen with beta-cyclodextrin derivatives: energetic and structural studies","volume":"55","author":"di Cagno","year":"2011","journal-title":"J. Pharm. Biomed."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0030","series-title":"Animal Clinical Chemistry","author":"Evans","year":"2009"},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0035","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1023\/A:1015929720063","article-title":"The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat","volume":"7","author":"Frijlink","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1015861719134","article-title":"The effect of parenterally administered cyclodextrins on cholesterol levels in the rat","volume":"8","author":"Frijlink","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0045","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","article-title":"2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review","volume":"43","author":"Gould","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/js960213f","article-title":"Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation","volume":"86","author":"Irie","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1248\/bpb1978.5.741","article-title":"Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro","volume":"5","author":"Irie","year":"1982","journal-title":"J. Pharmacobio-Dyn."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jps.2600810610","article-title":"Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans","volume":"81","author":"Irie","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2011.07.044","article-title":"Some pharmaceutical and inclusion properties of 2-hydroxybutyl-beta-cyclodextrin derivative","volume":"419","author":"Ishiguro","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.drudis.2015.11.017","article-title":"Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex","volume":"21","author":"Jambhekar","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.drudis.2015.11.016","article-title":"Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency","volume":"21","author":"Jambhekar","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpharm.2003.10.012","article-title":"The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes","volume":"270","author":"Jambhekar","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejvs.2011.10.017","article-title":"Safety, healing, and efficacy of vascular prostheses coated with hydroxypropyl-beta-cyclodextrin polymer: experimental in vitro and animal studies","volume":"43","author":"Jean-Baptiste","year":"2012","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2015.06.001","article-title":"Recent approaches for reducing hemolytic activity of chemotherapeutic agents","volume":"211","author":"Jeswani","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","article-title":"Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications","volume":"420","author":"Kawabata","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0100","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1021\/js970184o","article-title":"Lysis of human red blood cells. 4. Comparison of in vitro and in vivo hemolysis data","volume":"86","author":"Krzyzaniak","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jep.2015.10.002","article-title":"Acute and sub-chronic toxicity study of the ethanol extract from leaves of Aralia elata in rats","volume":"175","author":"Li","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0110","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/js950534b","article-title":"Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization","volume":"85","author":"Loftsson","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0115","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.2042-7158.2010.01030.x","article-title":"Pharmaceutical applications of cyclodextrins: basic science and product development","volume":"62","author":"Loftsson","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1773-2247(07)50001-8","article-title":"Cyclodextrins in ocular drug delivery: theoretical basis with dexamethasone as a sample drug","volume":"17","author":"Loftsson","year":"2007","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0125","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jps.2600750609","article-title":"Hydroxypropyl-beta-cyclodextrin derivatives: influence of average degree of substitution on complexing ability and surface activity","volume":"75","author":"Muller","year":"1986","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0130","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1021\/ie303440w","article-title":"Effect of hydroxypropyl-beta-cyclodextrin on the solubility of an antiarrhythmic agent","volume":"52","author":"Paduraru","year":"2013","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-5173(86)90201-2","article-title":"Hydroxypropyl-\u03b2-cyclodextrin: preparation and characterization; effects on solubility of drugs","volume":"29","author":"Pitha","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1085\/jgp.27.1.1","article-title":"The mechanism of the inhibition of hemolysis","volume":"27","author":"Ponder","year":"1943","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0145","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1208\/s12249-015-0344-7","article-title":"Improved aqueous solubility and antihypercholesterolemic activity of ezetimibe on formulating with hydroxypropyl-beta-cyclodextrin and hydrophilic auxiliary substances","volume":"17","author":"Srivalli","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0192623307310945","article-title":"Cyclodextrins","volume":"36","author":"Stella","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10847-006-9180-4","article-title":"Inclusion complex characterization between progesterone and hydroxypropyl-beta-cyclodextrin in aqueous solution by NMR study","volume":"57","author":"Torri","year":"2007","journal-title":"J. Incl. Phenom. Macro."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0160","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.fct.2011.03.026","article-title":"Evaluation of cholesterol depletion as a marker of nephrotoxicity in vitro for novel beta-cyclodextrin derivatives","volume":"49","author":"Wang","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0165","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1248\/cpb.37.1059","article-title":"Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities","volume":"37","author":"Yoshida","year":"1989","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jep.2012.04.030","article-title":"Polyprenols from Taxus chinensis var. mairei prevent the development of CCl(4)-induced liver fibrosis in rats","volume":"142","author":"Yu","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijpharm.2016.09.036_bib0175","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.carbpol.2010.09.007","article-title":"Preparation and physicochemical characteristics of the complex of edaravone with hydroxypropyl-beta-cyclodextrin","volume":"83","author":"Zeng","year":"2011","journal-title":"Carbohydr. Polym."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316308663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316308663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:34:58Z","timestamp":1759916098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316308663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0378517316308663"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.09.036","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison in toxicity and solubilizing capacity of hydroxypropyl-\u03b2-cyclodextrin with different degree of substitution","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.09.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}